November 17, 2025 · Form 4 insider transaction
Iannone Robert sold 7,159 shares of Jazz Pharmaceuticals plc at $168.26 per share, a transaction worth $1.20M. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.; The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.